LimmaTech Biologics Revenue

Biotechnology Research • Schlieren, Zurich, Switzerland • 51-100 Employees

LimmaTech Biologics revenue & valuation

Annual revenue	$3,500,000
Revenue per employee	$63,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$11,200,000
Total funding	$46,000,000

Key Contacts at LimmaTech Biologics

Franz-Werner Haas

Ceo

Lisa Prach

Associate Director Clinical Science

Paul Wolfrom

Co-Founder & Cfo

Elisabetta Greco

Senior Director - Head Of Legal & Intellectual Property

Gerd Lipowsky

Senior Director, Head Of Research

Cristina Alaimo

Senior Director, Head Of Clinical And Regulatory

Laura Yates

Associate Director

Company overview

Headquarters	Grabenstrasse 3, Schlieren, Zurich 8952, CH
Phone number	+41447338585
Website	lmtbio.com
NAICS	541714
SIC	873
Keywords	Biotechnology, Research & Development, Vaccines, Antimicrobial Resistance
Founded	2015
Employees	51-100
Socials

LimmaTech Biologics Email Formats

LimmaTech Biologics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@cuenote.jp), used 64.3% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@cuenote.jp	64.3%
{first name}{last name}	johndoe@cuenote.jp	35.7%

About LimmaTech Biologics

LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. In addition to our proprietary research, we also develop vaccines together with GSK.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Manager

Entry

Head

Employees by Department

LimmaTech Biologics has 22 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore LimmaTech Biologics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-11-09	4	$36,500,000
2024-03-01	4	$3,000,000
2025-03-17	9	$6,500,000

Funding Insights

$46,000,000

Total funding amount

$6,500,000

Most recent funding amount

Number of funding rounds

LimmaTech Biologics Tech Stack

Discover the technologies and tools that power LimmaTech Biologics's digital infrastructure, from frameworks to analytics platforms.

Hostpoint

Hosting

jQuery UI

JavaScript libraries

Google Maps

Maps

jQuery Migrate

JavaScript libraries

Apache HTTP Server

Web servers

BeTheme

WordPress themes

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

PHP

Programming languages

HSTS

Security

WordPress

Blogs

Frequently asked questions

LimmaTech Biologics is located in Schlieren, Zurich, CH.

You can reach LimmaTech Biologics at +41447338585.

LimmaTech Biologics generates an estimated annual revenue of $3,500,000. This revenue figure reflects the company's market position and business performance in its industry.

LimmaTech Biologics has an estimated valuation of $11,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

LimmaTech Biologics was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.

LimmaTech Biologics has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

LimmaTech Biologics has raised a total of $46,000,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at LimmaTech Biologics

Franz-Werner Haas

Ceo

Lisa Prach

Associate Director Clinical Science

Paul Wolfrom

Co-Founder & Cfo

Elisabetta Greco

Senior Director - Head Of Legal & Intellectual Property

Gerd Lipowsky

Senior Director, Head Of Research

Cristina Alaimo